Company Profile

Coris BioConcept is a leading expert of rapid in vitro diagnostics of human infectious diseases since 1996. Based in Belgium, the company develops, produces and markets IVD kits for respiratory, gastroenteric and blood-borne pathogens (bacteria, viruses and parasites) as well as serological assays, mainly based on the immunochromatographic technology (ICT).

Anti-Microbial Resistance concern pushed Coris BioConcept to develop a range of assays (RESIST) for rapid detection of antibiotic resistance mechanisms. Aside of this range, another innovative approach for 3GC detection was recently launched with a front line test: BL-RED.

This R&D expertise is ideally suited for “on demand” production of innovative solutions in a rapidly changing world that calls for cutting edge biotechnology to take us forward into a healthy future.

All Coris BioConcept’s products fulfil the CE marking requirements with an ISO 13485 certification and they are used in over 60 countries all over the world.

Coris BioConcept is now part of Avacta Group.

Discover our company and other complement information on www.corisbio.com